Niederer Kraft Frey advised the Ironman Group, an operator of mass participation sports in the world, on the acquisition of premier multi-day cycling event series Haute Route as well as the Gravel Epic, a soon-to-launch multi-day gravel race event series, both organised by Switzerland based Haute Route. With the acquisition of these two brands […]
Novaremed, a privately held clinical-stage biopharmaceutical company, expands its pipeline of non-opioid treatment candidates for chronic pain indications through the acquisition of Metys Pharmaceuticals. The acquisition broadens Novaremed’s existing pipeline by adding both
The insurer Zurich Switzerland, a Swiss subsidiary of the Zurich Insurance group, has acquired a 25% stake in the share capital of Brokerbusiness.ch., an insurtech start-up that operates a digital insurtech
Baker McKenzie advised Amsterdam-based Keesing Media Group (Keesing) on the acquisition of the Swiss Küng Group. The deal will enable Keesing to to strengthen its European market presence and develop a stronger foothold in
The Deutsche Börse Group, an international exchange organisation and innovative market infrastructure provider, acquires a majority of the shares in Crypto Finance, a Swiss crypto broker and asset manager. Through the acquisition, Deutsche Bö
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
Norres, a portfolio company of Triton Smaller Mid-Cap Fund I, acquired the Baggerman Group. The parties have agreed not to disclose the purchase price. The Baggerman Group, headquartered in Roermond, Netherlands, is a specialist
The city of Sierre, the association of the municipalities of the District of Sierre and TechnoArk acquired a majority stake in the Techno-Pôle of Sierre. Python acted as counsel to the buyers. Python team
Maus Frères and Coop-Group cooperative announced the sale of all shares of Jumbo-Markt, a Swiss do-it-yourself store operator, for an undisclosed consideration. Following merger control clearance by the Swiss Competition Commission the transaction has
Combioxin, a clinical phase biotechnology company based in Epalinges, Switzerland, has signed a worldwide commercial license agreement with Eagle Pharmaceuticals, a fully integrated pharmaceutical company based in Woodcliff Lake, NY, USA. Under the terms of
